š Disponible en #risalud hdl.handle.net/10668/30228

š Disponible en #risalud hdl.handle.net/10668/30228
Review of PRX5 in cancer stem cells š Low ROS sustain CSC self-renewal, drug resistance. š¬ PRX5 redox balance protects STAT3 from inactivation. š” Target: destabilize STAT3, reduce CSC self-renewal. DOI: https://doi.org/10.32604/biocell.2026.079386 #CancerStemCells #PRX5 #STAT3
Review of PRX5 in cancer stem cells š Low ROS sustain CSC self-renewal, drug resistance. š¬ PRX5 redox balance protects STAT3 from inactivation. š” Target: destabilize STAT3, reduce CSC self-renewal. DOI: https://doi.org/10.32604/biocell.2026.079386 #CancerStemCells #PRX5 #STAT3
Review of PRX5 in cancer stem cells š Low ROS sustain CSC self-renewal, drug resistance. š¬ PRX5 redox balance protects STAT3 from inactivation. š” Target: destabilize STAT3, reduce CSC self-renewal. DOI: https://doi.org/10.32604/biocell.2026.079386 #CancerStemCells #PRX5 #STAT3
Review of PRX5 in cancer stem cells š CSCs keep ROS low to self-renew and resist drugs. 𧬠PRX5 redox balance shields STAT3 from degradation. š” Targetable: prognostic biomarker, therapy target. DOI: https://doi.org/10.32604/biocell.2026.079386 #CancerStemCells #STAT3
Review of PRX5 in cancer stem cells š CSCs keep ROS low to self-renew and resist drugs. 𧬠PRX5 redox balance shields STAT3 from degradation. š” Targetable: prognostic biomarker, therapy target. DOI: https://doi.org/10.32604/biocell.2026.079386 #CancerStemCells #STAT3
Review of PRX5 in cancer stem cells š CSCs keep ROS low to self-renew and resist drugs. 𧬠PRX5 redox balance shields STAT3 from degradation. š” Targetable: prognostic biomarker, therapy target. DOI: https://doi.org/10.32604/biocell.2026.079386 #CancerStemCells #STAT3
Sharing a visualization from ongoing work on cancer stem cell (CSC) clonal dynamics under therapeutic pressure.
#CancerStemCells #TumorHeterogeneity #ClonalEvolution #MinimalResidualDisease #TumorPlasticity #DrugTolerantPersisters #SingleCellGenomics #PhylogeneticReconstruction